View Author
scopus: 6603638098

Vianen, W. van

(Wim van Vianen)


treatment agent infection concentration study ef ficacy activity effect agents chemother caspofungin survival antimicrob inoculation chemother ficacy antifungal combination 10 days amphotericin b mycobacterium avium /liter therapy mycobacterium avium liposomes model amb-doc result number susceptibility fumigatu growth clarithromycin albicans le-mtppe hyphal pharmacokinetic amphotericin strain hamb-doc blood amikacin signi animal t cells dosage hyphal clumps table mycobacterial aspergillosi aspergillu neutropenic 10 mg /kg antimycobacterial schedule patient liposomal addition value exposure bactericidal signi ficantly antimycobacterial agents transiently neutropenic rats ethambutol mycobacteria level hyphal fragments 21 days voriconazole pneumoniae parameter control hcamb-doc toxicity leukopenic mice antimicrobial conidia regimen administration




9 Most Recent Publications

The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus (Article)
Sande, W.W.J. van de Tavakol, M. Vianen, W. van Bakker-Woudenberg, I.A.J.M.
2010-01-29
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin (Article)
Sande, W.W.J. van de Mathot, R.A.A. Kate, M.T. ten Vianen, W. van Tavakol, M. Rijnders, B.J.A. Bakker-Woudenberg, I.A.J.M.
2009-05-01
Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis (Article)
Sande, W.W.J. van de Vianen, W. van Kate, M.T. ten Vissers, J. Laurijsens, J. Tavakol, M. Rijnders, B.J.A. Mathot, R.A. Bakker-Woudenberg, I.A.J.M.
2008-04-01
Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice (Article)
Steenwinkel, J.E.M. de Vianen, W. van Kate, M.T. ten Verbrugh, H.A. Agtmael, M.A. van Schiffelers, R.M. Bakker-Woudenberg, I.A.J.M.
2007-11-01
Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination. (Article)
Bakker-Woudenberg, I.A.J.M. Vianen, W. van Soolingen, D. van Verbrugh, H.A. Agtmael, M.A. van
2005-06-01
Mild heating of amphotericin B-desoxycholate: effects on ultrastructure, in vitro activity and toxicity, and therapeutic efficacy in severe candidiasis in leukopenic mice (Article)
Etten, E.W.M. van Vianen, W. van Roovers, P. Frederik, P.M.
2000-01-01
Involvement of T cells in enhanced resistance to Klebsiella pneumoniae septicemia in mice treated with liposome-encapsulated muramyl tripeptide phosphatidylethanolamine or gamma interferon (Article)
Hagen, T.L.M. ten Vianen, W. van Savelkoul, H.F.J. Heremans, H. Buurman, W.A. Bakker-Woudenberg, I.A.J.M.
1998-01-01
Superior efficacy of liposomal amphotericin B with prolonged circulation in blood in the treatment of severe candidiasis in leukopenic mice (Article)
Etten, E.W.M. van Snijders, S.V. Vianen, W. van Bakker-Woudenberg, I.A.J.M.
1998-01-01
Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide (Article)
Melissen, P.M. Vianen, W. van Bakker-Woudenberg, I.A.J.M.
1994-01-01
  • rss icon RSS Publication Feed
  • foaf icon FOAF Profile